Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease

  Abstract: Inflammatory bowel disease (IBD) is often treated with biologics and immunomodulators, which can place elderly IBD patients at risk for serious and opportunistic infections. […]

Combining Biologic Agents in Inflammatory Bowel Disease

  G&H  What is the rationale for combining biologic agents in inflammatory bowel disease? MA  Most of the biologic agents that gastroenterologists are currently using are […]

Highlights of the AGA Technical Review on Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome

  G&H  Why was this technical review on functional diarrhea and diarrhea-predominant irritable bowel syndrome conducted? WC  Gastroenterologists and primary care physicians encounter patients with functional […]

Treatment De-Escalation in Patients With Inflammatory Bowel Disease

  Abstract: Inflammatory bowel disease follows a relapsing and remitting course that can be augmented with the use of various pharmacologic therapies. Treatments used to induce […]

Update on Pregnancy in Patients With Inflammatory Bowel Disease

  G&H  What is the current understanding of the relationship between inflammatory bowel disease and fertility? AA  Female patients whose inflammatory bowel disease (IBD) is under […]

The Expanding Role of Anti–IL-12 and/or Anti–IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease

  Abstract: The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in the […]

The Impact of Biologic Therapy on Outcomes of Inflammatory Bowel Disease Surgery

G&H  Has the rate of inflammatory bowel disease surgery changed since biologic agents were introduced?  EL  The surgical rate has decreased with the advent of biologic […]

Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease

  Abstract: Guidelines for dietary recommendations and nutritional therapy for patients with inflammatory bowel disease (IBD) are lacking, and patients are moving toward popular defined diets […]

Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease

  Abstract: Inflammatory bowel disease (IBD), which mainly comprises Crohn’s disease (CD) and ulcerative colitis (UC), is a term for chronic inflammatory diseases of the gut […]

The Role of Vitamin D in Elderly Inflammatory Bowel Disease Patients

  Abstract: The role of vitamin D has long been discussed in many chronic diseases, and its significance in inflammatory bowel disease has recently gained attention. […]

The Development of Patient-Reported Outcome Measures in Inflammatory Bowel Disease

G&H  What patient-reported outcome measures have traditionally been used in inflammatory bowel disease? PH  To some extent, every patient visit involves a physician asking the patient […]

The Use of Mobile Applications in the Management of Patients With Inflammatory Bowel Disease

  G&H  Currently, how common is the use of mobile applications for managing inflammatory bowel disease? MH  The use of mobile applications to manage inflammatory bowel […]

Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance

    Abstract: Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory, progressive cholangiopathy. In a clinically significant proportion of patients, the disease course of PSC is […]

Inflammatory Bowel Disease in Travelers

  G&H  Why are inflammatory bowel disease patients at higher risk for infection, including opportunistic infection? GR  The risk of infection is higher in patients with […]

Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease

  G&H  What is the rationale for using fecal microbiota transplantation to try to treat disease, particularly inflammatory bowel disease?  PM  The concept of using fecal […]

Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease

  G&H  How safe is vedolizumab? What is its side-effect profile? BF  Most drugs used to treat inflammatory bowel disease (IBD) are systemically immunosuppressive, which means […]

Contraceptive Use in Women With Inflammatory Bowel Disease

G&H  How common is inflammatory bowel disease in women of childbearing age? LG  Inflammatory bowel disease (IBD) impacts approximately 1.6 million Americans and is equally as […]

Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease

Abstract: The serrated neoplasia pathway is thought to account for up to 30% of sporadic colorectal cancer, but its role in inflammatory bowel disease (IBD)-related colorectal […]

Pain Management in Patients With Inflammatory Bowel Disease

  G&H  How prevalent are acute and chronic pain in patients with inflammatory bowel disease? ES  Acute pain, such as abdominal distress in the context of […]

Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease

  Abstract: Patients with inflammatory bowel disease (IBD) do not receive routine preventive care at the same rate as the general population. IBD places patients at […]

Millennium Medical Publishing, Inc